Natural Killer (NK) Cell Therapeutics Market Report

China Natural Killer (NK) Cell Therapeutics Industry Market Research Report 2023-2029

  • POSTDATE：Oct 12, 2023
  • PAGES：186
  • REPORT CODE：GMM1846284
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Natural Killer (NK) Cell Therapeutics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Takeda Pharmaceutical (Japan)

    • NantKwest Inc (USA)

    • Altor BioScience Corporation (USA)

    • NKT Therapeutics (USA)

    • Sorrento Therapeutics Inc (USA)

    • Affimed NV (Netherlands)

    • Innate Pharma SA (France)

    • Bristol-Myers Squibb (USA)

    By Type:

    • Lorvotuzumab Mertansine

    • Mogamulizumab

    • Others

    By Application:

    • Cardiovascular Diseases

    • Others

    • Cancer

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Natural Killer (NK) Cell Therapeutics Market Overview 2018-2029

    • 1.1 China Natural Killer (NK) Cell Therapeutics Industry Development Overview

    • 1.2 China Natural Killer (NK) Cell Therapeutics Industry Development History

    • 1.3 China Natural Killer (NK) Cell Therapeutics Industry Market Size (2018-2029)

    • 1.4 China Natural Killer (NK) Cell Therapeutics Market Analysis by Type from Production Side

      • 1.4.1 China Natural Killer (NK) Cell Therapeutics Production Volume, Production Value and Growth Rate of Lorvotuzumab Mertansine (2018-2029)

      • 1.4.2 China Natural Killer (NK) Cell Therapeutics Production Volume, Production Value and Growth Rate of Mogamulizumab (2018-2029)

      • 1.4.3 China Natural Killer (NK) Cell Therapeutics Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • 1.5 China Natural Killer (NK) Cell Therapeutics Market Analysis by Application from Consumption End

      • 1.5.1 China Natural Killer (NK) Cell Therapeutics Sales Volume, Sales Value and Growth Rate of Cardiovascular Diseases (2018-2029)

      • 1.5.2 China Natural Killer (NK) Cell Therapeutics Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.3 China Natural Killer (NK) Cell Therapeutics Sales Volume, Sales Value and Growth Rate of Cancer (2018-2029)

    • 1.6 China Natural Killer (NK) Cell Therapeutics Market Analysis by Region

      • 1.6.1 North China Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2018-2029

    Chapter 2 China Natural Killer (NK) Cell Therapeutics Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Natural Killer (NK) Cell Therapeutics Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Natural Killer (NK) Cell Therapeutics Market Status and Competition Analysis in 2023

      • 2.2.3 China Natural Killer (NK) Cell Therapeutics Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Natural Killer (NK) Cell Therapeutics Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Natural Killer (NK) Cell Therapeutics Industry Development

    Chapter 3 Natural Killer (NK) Cell TherapeuticsIndustry Chain Analysis

    • 3.1 Natural Killer (NK) Cell Therapeutics Industry Chain

    • 3.2 Natural Killer (NK) Cell Therapeutics Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Natural Killer (NK) Cell Therapeutics Market

    • 3.3 Natural Killer (NK) Cell Therapeutics Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Natural Killer (NK) Cell Therapeutics Market

    Chapter 4 China Natural Killer (NK) Cell Therapeutics Market, by Type

    • 4.1 China Natural Killer (NK) Cell Therapeutics Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Natural Killer (NK) Cell Therapeutics Total Production Volume and Growth Rate from Production Side

    • 4.5 China Natural Killer (NK) Cell Therapeutics Production Volume and Growth Rate, by Type

      • 4.5.1 China Natural Killer (NK) Cell Therapeutics Production Volume and Growth Rate of Lorvotuzumab Mertansine

      • 4.5.2 China Natural Killer (NK) Cell Therapeutics Production Volume and Growth Rate of Mogamulizumab

      • 4.5.3 China Natural Killer (NK) Cell Therapeutics Production Volume and Growth Rate of Others

    Chapter 5 China Natural Killer (NK) Cell Therapeutics Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Natural Killer (NK) Cell Therapeutics Total Market Size and Growth Rate from Consumption End

    • 5.5 China Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate, by Application

      • 5.5.1 China Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Cardiovascular Diseases

      • 5.5.2 China Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Others

      • 5.5.3 China Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Cancer

    Chapter 6 China Natural Killer (NK) Cell Therapeutics Market, by Region

    • 6.1 China Natural Killer (NK) Cell Therapeutics Production Volume and Production Value, by Region

    • 6.2 China Natural Killer (NK) Cell Therapeutics Sales Volume and Sales Value, by Region

    Chapter 7 North China Natural Killer (NK) Cell Therapeutics Market Analysis

    • 7.1 North China Natural Killer (NK) Cell Therapeutics Market, by Type

    • 7.2 North China Natural Killer (NK) Cell Therapeutics Market, by Application

    Chapter 8 Central China Natural Killer (NK) Cell Therapeutics Market Analysis

    • 8.1 Central China Natural Killer (NK) Cell Therapeutics Market, by Type

    • 8.2 Central China Natural Killer (NK) Cell Therapeutics Market, by Application

    Chapter 9 South China Natural Killer (NK) Cell Therapeutics Market Analysis

    • 9.1 South China Natural Killer (NK) Cell Therapeutics Market, by Type

    • 9.2 South China Natural Killer (NK) Cell Therapeutics Market, by Application

    Chapter 10 East China Natural Killer (NK) Cell Therapeutics Market Analysis

    • 10.1 East China Natural Killer (NK) Cell Therapeutics Market, by Type

    • 10.2 East China Natural Killer (NK) Cell Therapeutics Market, by Application

    Chapter 11 Northeast China Natural Killer (NK) Cell Therapeutics Market Analysis

    • 11.1 Northeast China Natural Killer (NK) Cell Therapeutics Market, by Type

    • 11.2 Northeast China Natural Killer (NK) Cell Therapeutics Market, by Application

    Chapter 12 Southwest China Natural Killer (NK) Cell Therapeutics Market Analysis

    • 12.1 Southwest China Natural Killer (NK) Cell Therapeutics Market, by Type

    • 12.2 Southwest China Natural Killer (NK) Cell Therapeutics Market, by Application

    Chapter 13 Northwest China Natural Killer (NK) Cell Therapeutics Market Analysis

    • 13.1 Northwest China Natural Killer (NK) Cell Therapeutics Market, by Type

    • 13.2 Northwest China Natural Killer (NK) Cell Therapeutics Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Takeda Pharmaceutical (Japan)

        • 14.1.1 Takeda Pharmaceutical (Japan) Company Profile

        • 14.1.2 Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 NantKwest Inc (USA)

        • 14.2.1 NantKwest Inc (USA) Company Profile

        • 14.2.2 NantKwest Inc (USA) Natural Killer (NK) Cell Therapeutics Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Altor BioScience Corporation (USA)

        • 14.3.1 Altor BioScience Corporation (USA) Company Profile

        • 14.3.2 Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 NKT Therapeutics (USA)

        • 14.4.1 NKT Therapeutics (USA) Company Profile

        • 14.4.2 NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Sorrento Therapeutics Inc (USA)

        • 14.5.1 Sorrento Therapeutics Inc (USA) Company Profile

        • 14.5.2 Sorrento Therapeutics Inc (USA) Natural Killer (NK) Cell Therapeutics Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Affimed NV (Netherlands)

        • 14.6.1 Affimed NV (Netherlands) Company Profile

        • 14.6.2 Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Innate Pharma SA (France)

        • 14.7.1 Innate Pharma SA (France) Company Profile

        • 14.7.2 Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Bristol-Myers Squibb (USA)

        • 14.8.1 Bristol-Myers Squibb (USA) Company Profile

        • 14.8.2 Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Market Performance

        • 14.8.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Natural Killer (NK) Cell Therapeutics Industry Research Conclusions

    • 15.2 Natural Killer (NK) Cell Therapeutics Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Natural Killer (NK) Cell Therapeutics Industry Market Size (2018-2029)

    • Figure China Natural Killer (NK) Cell Therapeutics Production Volume, Production Value and Growth Rate of Lorvotuzumab Mertansine (2018-2029)

    • Figure China Natural Killer (NK) Cell Therapeutics Production Volume, Production Value and Growth Rate of Mogamulizumab (2018-2029)

    • Figure China Natural Killer (NK) Cell Therapeutics Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Natural Killer (NK) Cell Therapeutics Sales Volume, Sales Value and Growth Rate of Cardiovascular Diseases (2018-2029)

    • Figure China Natural Killer (NK) Cell Therapeutics Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Natural Killer (NK) Cell Therapeutics Sales Volume, Sales Value and Growth Rate of Cancer (2018-2029)

    • Figure North China Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Central China Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure South China Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure East China Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Natural Killer (NK) Cell Therapeutics Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Natural Killer (NK) Cell Therapeutics Market Share by Type in 2018

    • Figure China Natural Killer (NK) Cell Therapeutics Market Share by Type in 2023

    • Figure China Natural Killer (NK) Cell Therapeutics Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Natural Killer (NK) Cell Therapeutics Production Volume and Growth Rate of Lorvotuzumab Mertansine (2018-2023)

    • Figure China Natural Killer (NK) Cell Therapeutics Production Volume and Growth Rate of Mogamulizumab (2018-2023)

    • Figure China Natural Killer (NK) Cell Therapeutics Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Natural Killer (NK) Cell Therapeutics Market Share by Application in 2018

    • Figure China Natural Killer (NK) Cell Therapeutics Market Share by Application in 2023

    • Figure China Natural Killer (NK) Cell Therapeutics Total Market Size and Growth Rate from Consumption End

    • Figure China Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Cardiovascular Diseases (2018-2023)

    • Figure China Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Others (2018-2023)

    • Figure China Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Cancer (2018-2023)

    • Table China Natural Killer (NK) Cell Therapeutics Production Volume by Region (2018-2023)

    • Table China Natural Killer (NK) Cell Therapeutics Production Volume Share by Region (2018-2023)

    • Figure China Natural Killer (NK) Cell Therapeutics Production Volume Share by Region (2018-2023)

    • Table China Natural Killer (NK) Cell Therapeutics Production Value by Region (2018-2023)

    • Table China Natural Killer (NK) Cell Therapeutics Production Value Share by Region (2018-2023)

    • Figure China Natural Killer (NK) Cell Therapeutics Production Value Share by Region (2018-2023)

    • Table China Natural Killer (NK) Cell Therapeutics Sales Volume by Region (2018-2023)

    • Table China Natural Killer (NK) Cell Therapeutics Sales Volume Share by Region (2018-2023)

    • Figure China Natural Killer (NK) Cell Therapeutics Sales Volume Share by Region (2018-2023)

    • Table China Natural Killer (NK) Cell Therapeutics Sales Value by Region (2018-2023)

    • Table China Natural Killer (NK) Cell Therapeutics Sales Value Share by Region (2018-2023)

    • Figure China Natural Killer (NK) Cell Therapeutics Sales Value Share by Region (2018-2023)

    • Table North China Natural Killer (NK) Cell Therapeutics Production Volume by Type (2018-2023)

    • Table North China Natural Killer (NK) Cell Therapeutics Production Volume Share by Type (2018-2023)

    • Figure North China Natural Killer (NK) Cell Therapeutics Production Volume Share by Type (2018-2023)

    • Table North China Natural Killer (NK) Cell Therapeutics Sales Volume by Application (2018-2023)

    • Table North China Natural Killer (NK) Cell Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure North China Natural Killer (NK) Cell Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Central China Natural Killer (NK) Cell Therapeutics Production Volume by Type (2018-2023)

    • Table Central China Natural Killer (NK) Cell Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Central China Natural Killer (NK) Cell Therapeutics Production Volume Share by Type (2018-2023)

    • Table Central China Natural Killer (NK) Cell Therapeutics Sales Volume by Application (2018-2023)

    • Table Central China Natural Killer (NK) Cell Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Central China Natural Killer (NK) Cell Therapeutics Sales Volume Share by Application (2018-2023)

    • Table South China Natural Killer (NK) Cell Therapeutics Production Volume by Type (2018-2023)

    • Table South China Natural Killer (NK) Cell Therapeutics Production Volume Share by Type (2018-2023)

    • Figure South China Natural Killer (NK) Cell Therapeutics Production Volume Share by Type (2018-2023)

    • Table South China Natural Killer (NK) Cell Therapeutics Sales Volume by Application (2018-2023)

    • Table South China Natural Killer (NK) Cell Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure South China Natural Killer (NK) Cell Therapeutics Sales Volume Share by Application (2018-2023)

    • Table East China Natural Killer (NK) Cell Therapeutics Production Volume by Type (2018-2023)

    • Table East China Natural Killer (NK) Cell Therapeutics Production Volume Share by Type (2018-2023)

    • Figure East China Natural Killer (NK) Cell Therapeutics Production Volume Share by Type (2018-2023)

    • Table East China Natural Killer (NK) Cell Therapeutics Sales Volume by Application (2018-2023)

    • Table East China Natural Killer (NK) Cell Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure East China Natural Killer (NK) Cell Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northeast China Natural Killer (NK) Cell Therapeutics Production Volume by Type (2018-2023)

    • Table Northeast China Natural Killer (NK) Cell Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northeast China Natural Killer (NK) Cell Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northeast China Natural Killer (NK) Cell Therapeutics Sales Volume by Application (2018-2023)

    • Table Northeast China Natural Killer (NK) Cell Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Natural Killer (NK) Cell Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Southwest China Natural Killer (NK) Cell Therapeutics Production Volume by Type (2018-2023)

    • Table Southwest China Natural Killer (NK) Cell Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Southwest China Natural Killer (NK) Cell Therapeutics Production Volume Share by Type (2018-2023)

    • Table Southwest China Natural Killer (NK) Cell Therapeutics Sales Volume by Application (2018-2023)

    • Table Southwest China Natural Killer (NK) Cell Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Natural Killer (NK) Cell Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northwest China Natural Killer (NK) Cell Therapeutics Production Volume by Type (2018-2023)

    • Table Northwest China Natural Killer (NK) Cell Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northwest China Natural Killer (NK) Cell Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northwest China Natural Killer (NK) Cell Therapeutics Sales Volume by Application (2018-2023)

    • Table Northwest China Natural Killer (NK) Cell Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Natural Killer (NK) Cell Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Takeda Pharmaceutical (Japan) Company Profile

    • Table Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Revenue, Price and Gross (2018-2023)

    • Table NantKwest Inc (USA) Company Profile

    • Table NantKwest Inc (USA) Natural Killer (NK) Cell Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Altor BioScience Corporation (USA) Company Profile

    • Table Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Revenue, Price and Gross (2018-2023)

    • Table NKT Therapeutics (USA) Company Profile

    • Table NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Sorrento Therapeutics Inc (USA) Company Profile

    • Table Sorrento Therapeutics Inc (USA) Natural Killer (NK) Cell Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Affimed NV (Netherlands) Company Profile

    • Table Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Innate Pharma SA (France) Company Profile

    • Table Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Bristol-Myers Squibb (USA) Company Profile

    • Table Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US